Philip Morris International Inc. (PM) stock
Close on Oct 30, 2026Market cap $325.42BP/E 30.0Yield 2.70%
Earnings
Philip Morris International's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.
Quarterly results
Revenue and earnings per share from each of Philip Morris International's earnings releases, newest first
| Quarter | Reported | Revenue | YoY | EPS | Adj. EPS | Source |
|---|---|---|---|---|---|---|
| Q4 FY2026ended Dec 31, 2026 | Feb 5, 2027Expected | – | – | – | – | – |
| Q3 FY2026ended Sep 30, 2026 | Oct 21, 2026before the open | $11.40B | +5.6% | $2.12 | $2.36 | Release |
| Q2 FY2026ended Jun 30, 2026 | Jul 22, 2026before the open | $11.20B | +10.5% | $1.80 | $2.20 | Release |
| Q1 FY2026ended Mar 31, 2026 | Apr 22, 2026before the open | $10.10B | +8.6% | $1.56 | $1.96 | Release |
| Q4 FY2025ended Dec 31, 2025 | Feb 6, 2026before the open | $10.36B | +6.8% | – | – | Release |
| Q3 FY2025ended Sep 30, 2025 | Oct 21, 2025before the open | $10.80B | +9.0% | $2.23 | $2.24 | Release |
| Q2 FY2025ended Jun 30, 2025 | Jul 22, 2025before the open | $10.14B | +7.1% | $1.95 | $1.91 | Release |
| Q1 FY2025ended Mar 31, 2025 | Apr 23, 2025before the open | $9.30B | +5.8% | $1.72 | $1.69 | Release |
| Q4 FY2024ended Dec 31, 2024 | Feb 6, 2025before the open | $9.71B | +7.8% | – | – | Release |
| Q3 FY2024ended Sep 30, 2024 | Oct 22, 2024before the open | $9.91B | +8.4% | $1.97 | $1.91 | Release |
| Q2 FY2024ended Jun 30, 2024 | Jul 23, 2024before the open | $9.47B | +5.6% | $1.54 | $1.59 | Release |
| Q1 FY2024ended Mar 31, 2024 | Apr 23, 2024before the open | $8.79B | +9.9% | $1.38 | $1.50 | Release |
| Q4 FY2023ended Dec 31, 2023 | Feb 8, 2024before the open | $9.00B | +10.4% | $1.41 | $1.36 | Release |
| Q3 FY2023ended Sep 30, 2023 | Oct 19, 2023before the open | $9.14B | +13.8% | $1.32 | $1.67 | Release |
| Q2 FY2023ended Jun 30, 2023 | Jul 20, 2023before the open | $8.97B | +14.5% | $1.01 | $1.60 | Release |
| Q1 FY2023ended Mar 31, 2023 | Apr 20, 2023before the open | $8.00B | +3.3% | $1.28 | $1.38 | Release |
| Q4 FY2022ended Dec 31, 2022 | Feb 9, 2023before the open | $8.15B | +0.6% | $1.54 | $1.23 | Release |
| Q3 FY2022ended Sep 30, 2022 | Oct 20, 2022before the open | $8.03B | -1.1% | $1.34 | $1.53 | Release |
| Q2 FY2022ended Jun 30, 2022 | Jul 21, 2022before the open | $7.83B | – | $1.43 | $1.48 | Release |
| Q1 FY2022ended Mar 31, 2022 | Apr 21, 2022before the open | $7.75B | – | $1.50 | $1.56 | Release |
| Q4 FY2021ended Dec 31, 2021 | Feb 10, 2022before the open | $8.10B | – | $1.34 | $1.35 | Release |
| Q3 FY2021ended Sep 30, 2021 | Oct 19, 2021before the open | $8.12B | – | $1.55 | $1.58 | Release |
| Q2 FY2021ended Jun 30, 2021 | Jul 20, 2021before the open | – | – | – | – | Filing |
| Q1 FY2021ended Mar 31, 2021 | Apr 20, 2021before the open | – | – | – | – | Filing |
| Q4 FY2020ended Dec 31, 2020 | Feb 4, 2021before the open | – | – | – | – | Filing |
| Q3 FY2020ended Sep 30, 2020 | Oct 20, 2020before the open | – | – | – | – | Filing |
Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.
Current guidance
Philip Morris International's latest outlook for periods it has not reported yet, compared with what it said before
| Metric | Period | Guidance | Before | Change | Given |
|---|---|---|---|---|---|
| Net revenue growthnon-GAAP | FY2026 | +5% – +7% | – | New | Oct 21, 2026 |
| Net revenue growth on an organic basisnon-GAAP | FY2026 | +5% – +7% | +5% – +7% | Reaffirmed | Jul 22, 2026 |
| Organic operating income growthnon-GAAP | FY2026 | +7% – +9% | – | New | Oct 21, 2026 |
| Organic operating income growthnon-GAAP | FY2026 | +7% – +9% | +7% – +9% | Reaffirmed | Jul 22, 2026 |
| Reported diluted EPSGAAP | FY2026 | $7.11 – $7.26 | – | New | Oct 21, 2026 |
| Reported diluted EPSGAAP | FY2026 | $7.19 – $7.34 | $7.56 – $7.71 | Lowered | Jul 22, 2026 |
| Adjusted Diluted EPSnon-GAAP | FY2026 | $8.29 – $8.44 | – | New | Oct 21, 2026 |
| Adjusted Diluted EPSnon-GAAP | FY2026 | $8.26 – $8.41 | $8.36 – $8.51 | Lowered | Jul 22, 2026 |
| projected increase versus adjusted diluted EPS in 2025 excluding currencynon-GAAP | FY2026 | +7.5% – +9.5% | +11.1% – +13.1% | Lowered | Jul 22, 2026 |
| Capital expenditures | FY2026 | $1.40B – $1.60B | – | New | Oct 21, 2026 |
| Capital expenditures | FY2026 | $1.40B – $1.60B | $1.40B – $1.60B | Reaffirmed | Jul 22, 2026 |
| effective tax rate, excluding discrete tax eventsnon-GAAP | FY2026 | 21.5% | – | New | Oct 21, 2026 |
| effective tax rate, excluding discrete tax events | FY2026 | 21.5% | – | New | Jul 22, 2026 |
| Full-year amortization of acquired intangibles per share | FY2026 | $0.50 | – | New | Jul 22, 2026 |
| net debt to adjusted EBITDA ratio | FY2026 | 2 | – | New | Jul 22, 2026 |
| Operating cash flow | FY2026 | $13.50B | – | New | Oct 21, 2026 |
| Operating cash flow | FY2026 | $13.50B | $13.50B | Reaffirmed | Jul 22, 2026 |
Guidance vs results
The last range Philip Morris International gave before each report, against the figure it then reported. Full years add up the four quarters.
| Period | Metric | Guidance | Actual | Result |
|---|---|---|---|---|
| Q3 FY2026 | adjusted diluted EPS | $2.20 – $2.25 | $2.36 | Above range |
| Q2 FY2026 | adjusted diluted EPS | $2.02 – $2.07 | $2.20 | Above range |
| Q1 FY2026 | First quarter adjusted diluted EPS | $1.80 – $1.85 | $1.96 | Above range |
| FY2025 | Revenue growth | +6% – +8% | +7.19%Σ4Q | Within range |
| Q3 FY2025 | adjusted diluted EPS | $2.08 – $2.13 | $2.24 | Above range |
| Q2 FY2025 | Second quarter adjusted diluted EPS | $1.80 – $1.85 | $1.91 | Above range |
| Q1 FY2025 | First quarter adjusted diluted EPS | $1.58 – $1.63 | $1.69 | Above range |
| Q3 FY2024 | third quarter adjusted diluted EPS | $1.77 – $1.82 | $1.91 | Above range |
| Q2 FY2024 | second quarter adjusted diluted EPS | $1.50 – $1.55 | $1.59 | Above range |
| Q1 FY2024 | adjusted diluted EPS | $1.37 – $1.42 | $1.50 | Above range |
| Q3 FY2023 | adjusted diluted EPS | $1.60 – $1.65 | $1.67 | Above range |
| Q2 FY2023 | adjusted diluted EPS | $1.42 – $1.47 | $1.60 | Above range |
| Q1 FY2023 | EPS (GAAP) | $1.28 – $1.33 | $1.28 | Within range |
| Q3 FY2022 | Pro forma third-quarter adjusted diluted EPS | $1.23 – $1.28 | $1.53 | Above range |
| Q2 FY2022 | Pro forma second-quarter adjusted diluted EPS | $1.19 – $1.24 | $1.48 | Above range |
| Q1 FY2022 | EPS (GAAP) | $1.50 – $1.55 | $1.50 | Within range |
Guidance history
Every forecast Philip Morris International put in an earnings release, newest first
| Given | Metric | Period | Guidance | Change |
|---|---|---|---|---|
| Oct 21, 2026 | Capital expenditures | FY2026 | $1.40B – $1.60B | New |
| Oct 21, 2026 | Adjusted Diluted EPS | FY2026 | $8.29 – $8.44 | New |
| Oct 21, 2026 | Reported diluted EPS | FY2026 | $7.11 – $7.26 | New |
| Oct 21, 2026 | Organic operating income growth | FY2026 | +7% – +9% | New |
| Oct 21, 2026 | effective tax rate, excluding discrete tax events | FY2026 | 21.5% | New |
| Oct 21, 2026 | Operating cash flow | FY2026 | $13.50B | New |
| Oct 21, 2026 | Net revenue growth | FY2026 | +5% – +7% | New |
| Jul 22, 2026 | Capital expenditures | FY2026 | $1.40B – $1.60B | Reaffirmed |
| Jul 22, 2026 | projected increase versus adjusted diluted EPS in 2025 excluding currency | FY2026 | +7.5% – +9.5% | Lowered |
| Jul 22, 2026 | projected increase versus adjusted diluted EPS in 2025 | FY2026 | +9.5% – +11.5% | Raised |
| Jul 22, 2026 | Adjusted Diluted EPS | FY2026 | $8.26 – $8.41 | Lowered |
| Jul 22, 2026 | Adjusted Diluted EPS, excluding currency | FY2026 | $8.11 – $8.26 | Lowered |
| Jul 22, 2026 | adjusted diluted EPS | Q3 FY2026 | $2.20 – $2.25 | New |
| Jul 22, 2026 | Reported diluted EPS | FY2026 | $7.19 – $7.34 | Lowered |
| Jul 22, 2026 | Organic operating income growth | FY2026 | +7% – +9% | Reaffirmed |
| Jul 22, 2026 | net debt to adjusted EBITDA ratio | FY2026 | 2 | New |
| Jul 22, 2026 | effective tax rate, excluding discrete tax events | FY2026 | 21.5% | New |
| Jul 22, 2026 | Operating cash flow | FY2026 | $13.50B | Reaffirmed |
| Jul 22, 2026 | Full-year amortization of acquired intangibles per share | FY2026 | $0.50 | New |
| Jul 22, 2026 | Net revenue growth on an organic basis | FY2026 | +5% – +7% | Reaffirmed |
| Apr 22, 2026 | Capital expenditures | FY2026 | $1.40B – $1.60B | Reaffirmed |
| Apr 22, 2026 | Adjusted Diluted EPS | FY2026 | $8.36 – $8.51 | Raised |
| Apr 22, 2026 | adjusted diluted EPS | Q2 FY2026 | $2.02 – $2.07 | New |
| Apr 22, 2026 | Reported Diluted EPS | FY2026 | $7.56 – $7.71 | Lowered |
| Apr 22, 2026 | Organic operating income growth | FY2026 | +7% – +9% | Reaffirmed |
| Apr 22, 2026 | Net revenue growth on an organic basis | FY2026 | +5% – +7% | Reaffirmed |
| Feb 6, 2026 | Capital expenditures | FY2026 | $1.40B – $1.60B | New |
| Feb 6, 2026 | Adjusted Diluted EPS growth | FY2026 | +11.1% – +13.1% | New |
| Feb 6, 2026 | adjusted diluted EPS, excluding currency | 2026 to 2028 | +9% – +11% | – |
| Feb 6, 2026 | Adjusted Diluted EPS, excluding currency | FY2026 | $8.11 – $8.26 | Lowered |
| Feb 6, 2026 | First quarter adjusted diluted EPS | Q1 FY2026 | $1.80 – $1.85 | New |
| Feb 6, 2026 | Adjusted Diluted EPS, excluding currency growth | FY2026 | +7.5% – +9.5% | Lowered |
| Feb 6, 2026 | Adjusted Diluted EPS | FY2026 | $8.38 – $8.53 | New |
| Feb 6, 2026 | Reported Diluted EPS | FY2026 | $7.87 – $8.02 | New |
| Feb 6, 2026 | operating income, on an organic basis | 2026 to 2028 | +8% – +10% | – |
| Feb 6, 2026 | Organic operating income growth | FY2026 | +7% – +9% | New |
| Feb 6, 2026 | Operating cash flow | FY2026 | $13.50B | New |
| Feb 6, 2026 | Net revenue growth on an organic basis | FY2026 | +5% – +7% | New |
| Feb 6, 2026 | net revenues, on an organic basis | 2026 to 2028 | +6% – +8% | – |
| Oct 21, 2025 | Capital expenditures | FY2025 | $1.60B | New |
| Oct 21, 2025 | Adjusted Diluted EPS | FY2025 | $7.46 – $7.56 | Raised |
| Oct 21, 2025 | Reported Diluted EPS | FY2025 | $7.39 – $7.49 | Raised |
| Oct 21, 2025 | Organic operating income growth | FY2025 | +10% – +11.5% | Lowered |
| Oct 21, 2025 | effective tax rate, excluding discrete tax events | FY2025 | 22% | New |
| Oct 21, 2025 | Operating cash flow | FY2025 | $11.50B | New |
| Oct 21, 2025 | Full-year amortization of acquired intangibles | FY2025 | $0.50 | New |
| Oct 21, 2025 | Net revenue growth | FY2025 | +6% – +8% | Reaffirmed |
| Jul 22, 2025 | Capital expenditures | FY2025 | $1.60B | New |
| Jul 22, 2025 | Adjusted Diluted EPS growth | FY2025 | +13% – +15% | New |
| Jul 22, 2025 | Adjusted Diluted EPS, excluding currency growth | FY2025 | +11.5% – +13.5% | Lowered |
| Jul 22, 2025 | Adjusted Diluted EPS | FY2025 | $7.43 – $7.56 | New |
| Jul 22, 2025 | Adjusted Diluted EPS, excluding currency | FY2025 | $7.33 – $7.46 | Lowered |
| Jul 22, 2025 | adjusted diluted EPS | Q3 FY2025 | $2.08 – $2.13 | New |
| Jul 22, 2025 | Reported Diluted EPS | FY2025 | $7.24 – $7.37 | New |
| Jul 22, 2025 | Organic operating income growth | FY2025 | +11% – +12.5% | New |
| Jul 22, 2025 | Net revenue growth of around 6% to 8% on an organic basis | FY2025 | +6% – +8% | New |
| Apr 23, 2025 | Capital expenditures | FY2025 | $1.50B | Reaffirmed |
| Apr 23, 2025 | Second quarter adjusted diluted EPS | Q2 FY2025 | $1.80 – $1.85 | New |
| Apr 23, 2025 | Adjusted Diluted EPS | FY2025 | $7.36 – $7.49 | Raised |
| Apr 23, 2025 | Reported Diluted EPS | FY2025 | $7.01 – $7.14 | Raised |
| Apr 23, 2025 | Organic operating income growth | FY2025 | +10.5% – +12.5% | Reaffirmed |
| Apr 23, 2025 | Net revenue growth | FY2025 | +6% – +8% | Reaffirmed |
| Feb 6, 2025 | Capital expenditures | FY2025 | $1.50B | New |
| Feb 6, 2025 | First quarter adjusted diluted EPS | Q1 FY2025 | $1.58 – $1.63 | New |
| Feb 6, 2025 | Adjusted Diluted EPS | FY2025 | $7.04 – $7.17 | New |
| Feb 6, 2025 | Reported Diluted EPS | FY2025 | $6.55 – $6.68 | New |
| Feb 6, 2025 | Organic operating income growth | FY2025 | +10.5% – +12.5% | New |
| Feb 6, 2025 | Net revenue growth on an organic basis | FY2025 | +6% – +8% | New |
| Oct 22, 2024 | Capital expenditures | FY2024 | $1.40B | Raised |
| Oct 22, 2024 | projected increase versus adjusted diluted EPS in 2023 | FY2024 | +7.3% – +8.3% | New |
| Oct 22, 2024 | full-year growth outlook for adjusted diluted EPS, excluding currency | FY2024 | +14% – +15% | Raised |
| Oct 22, 2024 | Adjusted Diluted EPS | FY2024 | $6.45 – $6.51 | Raised |
| Oct 22, 2024 | Adjusted Diluted EPS, excluding currency | FY2024 | $6.85 – $6.91 | Raised |
| Oct 22, 2024 | Reported Diluted EPS | FY2024 | $6.20 – $6.26 | Raised |
| Oct 22, 2024 | Organic operating income growth | FY2024 | +14% – +14.5% | Raised |
| Oct 22, 2024 | HTU shipment volumes | FY2024 | 140 | New |
| Oct 22, 2024 | Nicotine pouch shipment volume in the U.S. | FY2024 | 570 – 580 | Raised |
| Oct 22, 2024 | effective tax rate, excluding discrete tax events | FY2024 | 21% – 22% | New |
| Oct 22, 2024 | Total cigarette, HTU and oral smoke-free product shipment volume growth | FY2024 | +2% – +3% | New |
| Oct 22, 2024 | HTU adjusted IMS growth | FY2024 | +13% | New |
| Oct 22, 2024 | Operating cash flow | FY2024 | $11.00B | Raised |
| Oct 22, 2024 | Net financing costs | FY2024 | $1.10B – $1.20B | Lowered |
| Oct 22, 2024 | Full-year amortization of acquired intangibles | FY2024 | $0.42 | New |
| Oct 22, 2024 | Net revenue growth on an organic basis | FY2024 | +9.5% | Raised |
| Jul 23, 2024 | Capital expenditures | FY2024 | $1.30B – $1.40B | Raised |
| Jul 23, 2024 | third quarter adjusted diluted EPS | Q3 FY2024 | $1.77 – $1.82 | New |
| Jul 23, 2024 | Adjusted Diluted EPS | FY2024 | $6.33 – $6.45 | Raised |
| Jul 23, 2024 | Reported diluted EPS | FY2024 | $5.89 – $6.01 | Raised |
| Jul 23, 2024 | Organic operating income growth | FY2024 | +11% – +13% | Raised |
| Jul 23, 2024 | Net revenue growth | FY2024 | +7.5% – +9% | Raised |
| Apr 23, 2024 | Capital expenditures | FY2024 | $1.20B | Reaffirmed |
| Apr 23, 2024 | second quarter adjusted diluted EPS | Q2 FY2024 | $1.50 – $1.55 | New |
| Apr 23, 2024 | Adjusted Diluted EPS | FY2024 | $6.19 – $6.31 | Lowered |
| Apr 23, 2024 | Reported diluted EPS | FY2024 | $5.70 – $5.82 | Lowered |
| Apr 23, 2024 | Organic operating income growth | FY2024 | +10% – +12% | Raised |
| Apr 23, 2024 | Net revenue growth | FY2024 | +7% – +8.5% | Raised |
| Feb 8, 2024 | Capital expenditures | FY2024 | $1.20B | New |
| Feb 8, 2024 | adjusted diluted EPS | Q1 FY2024 | $1.37 – $1.42 | New |
| Feb 8, 2024 | Adjusted Diluted EPS | FY2024 | $6.32 – $6.44 | New |
| Feb 8, 2024 | Reported diluted EPS | FY2024 | $5.90 – $6.02 | New |
| Feb 8, 2024 | Organic operating income growth | FY2024 | +8% – +9.5% | New |
| Feb 8, 2024 | effective tax rate, excluding discrete tax events | FY2024 | 21% – 22% | New |
| Feb 8, 2024 | Operating cash flow | FY2024 | $10.00B – $11.00B | New |
| Feb 8, 2024 | Net financing costs | FY2024 | $1.30B – $1.40B | Lowered |
| Feb 8, 2024 | Net revenue growth | FY2024 | +6.5% – +8% | New |
| Oct 19, 2023 | Capital expenditures | FY2023 | $1.30B | Reaffirmed |
| Oct 19, 2023 | Adjusted Diluted EPS | FY2023 | $6.05 – $6.08 | Lowered |
| Oct 19, 2023 | Reported diluted EPS | FY2023 | $4.95 – $4.98 | Lowered |
| Oct 19, 2023 | Nicotine pouch shipment volume | FY2023 | 390 – 410 | New |
| Oct 19, 2023 | effective tax rate, excluding discrete tax events | FY2023 | 20.5% – 21.5% | New |
| Oct 19, 2023 | Total cigarette and HTU shipment volume growth | FY2023 | +1% – +1.5% | New |
| Oct 19, 2023 | cigarette shipment volume decline | FY2023 | +1% – +2% | Raised |
| Oct 19, 2023 | Operating cash flow | FY2023 | $10.00B | New |
| Oct 19, 2023 | Net financing costs | FY2023 | $1.10B | Lowered |
| Oct 19, 2023 | Net revenue growth | FY2023 | +8% | Narrowed |
| Jul 20, 2023 | Capital expenditures | FY2023 | $1.30B | Reaffirmed |
| Jul 20, 2023 | adjusted diluted EPS | Q3 FY2023 | $1.60 – $1.65 | New |
| Jul 20, 2023 | ADJUSTED DILUTED EPS | FY2023 | $6.13 – $6.22 | Raised |
| Jul 20, 2023 | Reported diluted EPS | FY2023 | $5.36 – $5.45 | Lowered |
| Jul 20, 2023 | organic net revenue growth | FY2023 | +7.5% – +8.5% | Raised |
| Apr 20, 2023 | Capital expenditures | FY2023 | $1.30B | Reaffirmed |
| Apr 20, 2023 | adjusted diluted EPS | Q2 FY2023 | $1.42 – $1.47 | New |
| Apr 20, 2023 | Adjusted Diluted EPS | FY2023 | $6.10 – $6.22 | Lowered |
| Apr 20, 2023 | Reported diluted EPS | FY2023 | $5.88 – $6.00 | Lowered |
| Apr 20, 2023 | Net revenue growth | FY2023 | +7% – +8.5% | Reaffirmed |
| Feb 9, 2023 | Capital expenditures | FY2023 | $1.30B | New |
| Feb 9, 2023 | Adjusted Diluted EPS | FY2023 | $6.25 – $6.37 | New |
| Feb 9, 2023 | First-quarter reported diluted EPS | Q1 FY2023 | $1.28 – $1.33 | New |
| Feb 9, 2023 | Reported diluted EPS | FY2023 | $6.09 – $6.21 | New |
| Feb 9, 2023 | Net revenue growth | FY2023 | +7% – +8.5% | New |
| Oct 20, 2022 | Capital expenditures | FY2022 | $1.00B | Reaffirmed |
| Oct 20, 2022 | ADJUSTED DILUTED EPS | FY2022 | $5.81 – $5.96 | Raised |
| Oct 20, 2022 | Reported diluted EPS | FY2022 | $5.47 – $5.62 | Lowered |
| Oct 20, 2022 | Pro forma adjusted net revenue growth | FY2022 | +6.5% – +8% | Raised |
| Jul 21, 2022 | Capital expenditures | FY2022 | $1.00B | Reaffirmed |
| Jul 21, 2022 | Pro forma third-quarter adjusted diluted EPS | Q3 FY2022 | $1.23 – $1.28 | New |
| Jul 21, 2022 | PRO FORMA ADJUSTED DILUTED EPS | FY2022 | $5.23 – $5.34 | Lowered |
| Jul 21, 2022 | Reported diluted EPS | FY2022 | $5.73 – $5.88 | Raised |
| Jul 21, 2022 | Pro forma adjusted net revenue growth | FY2022 | +6% – +8% | Raised |
| Apr 21, 2022 | Capital expenditures | FY2022 | $1.00B | Reaffirmed |
| Apr 21, 2022 | Pro forma second-quarter adjusted diluted EPS | Q2 FY2022 | $1.19 – $1.24 | New |
| Apr 21, 2022 | Pro Forma Adjusted Diluted EPS | FY2022 | $5.35 – $5.46 | Lowered |
| Apr 21, 2022 | Reported diluted EPS | FY2022 | $5.39 – $5.50 | Lowered |
| Apr 21, 2022 | Pro forma adjusted net revenue growth | FY2022 | +4.5% – +6.5% | Raised |
| Feb 10, 2022 | Capital expenditures | FY2022 | $1.00B | New |
| Feb 10, 2022 | Adjusted Diluted EPS | FY2022 | $6.12 – $6.30 | New |
| Feb 10, 2022 | reported diluted EPS | Q1 FY2022 | $1.50 – $1.55 | New |
| Feb 10, 2022 | Reported diluted EPS | FY2022 | $6.12 – $6.30 | New |
| Feb 10, 2022 | Adjusted net revenue growth | FY2022 | +4% – +6% | New |
| Oct 19, 2021 | Capital expenditures | FY2021 | $600.00M | New |
| Oct 19, 2021 | Adjusted Diluted EPS | FY2021 | $6.01 – $6.06 | New |
| Oct 19, 2021 | reported diluted EPS | FY2021 | $5.77 – $5.82 | New |
| Oct 19, 2021 | Adjusted net revenue growth | FY2021 | +6.5% – +7% | New |
Read from the company's earnings releases; each figure links to its sentence on hover. “Raised” and “Lowered” compare with the previous range for the same metric and period.
Press releases
Releases Philip Morris International filed with the SEC as exhibits to Form 8-K or 6-K
- Results
- Results
- Update
- Update
- Update
- Update
- Results
- Results
- Update
- Update
- Update
- Update
- Results
- Results
- Update